Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04731467
Title A Study of CM24 in Combination With Nivolumab in Adults With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Famewave Ltd.
Indications

ovarian cancer

pancreatic adenocarcinoma

colorectal adenocarcinoma

pancreatic cancer

thyroid gland papillary carcinoma

lung non-small cell carcinoma

melanoma

Therapies

CM-24 + Nivolumab

CM-24 + Nab-paclitaxel + Nivolumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
HonorHealth Research Institute Recruiting Scottsdale Arizona 85258 United States Details
Yale University Recruiting New Haven Connecticut 06520 United States Details
Barbara Ann Karmanos Cancer Institute Recruiting Detroit Michigan 48201 United States Details
The University of Texas M.D. Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
Rambam Health Care Campus Recruiting Haifa Israel Details
Sheba Medical Center Recruiting Ramat Gan Israel Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field